MMM · XBRL financial data

3M Company financial statements, every fiscal year

The same tables from 7 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal years (MMM's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Revenue	32,184	35,355	34,229	32,681	24,575	24,948
Revenue from contracts with customers	32,184	35,355	34,229	24,610	24,575	24,948
Cost of revenue	16,605	18,795	19,232	18,477	14,447	14,991
Research and development	1,146	1,243	1,100	1,000	700	—
Selling, general and administrative	6,929	7,197	9,049	21,526	4,221	3,997
Operating income (loss)	7,161	7,369	6,539	(9,128)	4,822	4,629
Interest expense	529	488	462	942	1,191	946
Income tax expense (benefit)	1,318	1,285	612	(2,691)	804	1,003
Net income (loss)	5,384	5,921	5,777	(6,995)	4,173	3,250
Earnings per share, basic USD per share	9.32	10.23	10.21	(12.63)	7.58	6.05
Earnings per share, diluted USD per share	9.25	10.12	10.18	(12.63)	7.55	6.00
Weighted average shares, basic millions of shares	578	579	566	554	551	537
Weighted average shares, diluted millions of shares	582	585	568	554	552	541

Fiscal years (MMM's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Cash and cash equivalents	4,634	4,564	3,655	5,933	5,600	5,235
Marketable securities	404	—	—	—	—	—
Marketable securities, non-current	30	—	—	—	—	—
Accounts receivable	4,705	4,660	4,532	4,750	3,194	3,533
Inventory	4,239	4,985	5,372	4,822	3,698	3,661
Total current assets	14,982	15,403	14,688	16,379	15,884	16,387
Property and equipment, net	9,421	9,429	9,178	9,159	7,388	7,101
Right-of-use asset	864	858	829	759	565	516
Goodwill	13,802	13,486	12,790	12,927	6,281	6,419
Total assets	47,344	47,072	46,455	50,580	39,868	37,733
Accounts payable	2,561	2,994	3,183	3,245	2,660	2,702
Commercial paper	0	—	—	—	—	—
Current portion of long-term debt	794	1,291	1,938	1,152	1,919	1,670
Total current liabilities	7,948	9,035	9,523	15,297	11,256	9,595
Long-term debt	17,989	16,056	14,001	13,088	11,125	10,932
Lease liability, non-current	609	591	580	534	405	363
Total liabilities	34,413	31,955	31,685	45,712	35,974	32,986
Retained earnings	43,761	45,821	47,950	37,479	36,797	38,258
Total stockholders' equity	12,867	15,046	14,722	4,807	3,842	4,702
Total liabilities and equity	47,344	47,072	46,455	50,580	39,868	37,733
Common shares outstanding (cover page) millions of shares	579	571	551	553	543	527

Fiscal years (MMM's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Net income (loss)	5,384	5,921	5,777	(6,995)	4,173	3,250
Stock-based compensation	262	274	263	274	289	225
Depreciation and amortization	1,911	1,915	1,831	1,987	1,363	1,308
Net cash from operating activities	8,113	7,454	5,591	6,680	1,819	2,306
Purchases of property and equipment	1,501	1,603	1,749	1,615	1,181	910
Net cash from investing activities	(580)	(1,317)	(1,046)	(1,207)	(3,206)	1,350
Share repurchases	368	2,199	1,464	33	1,801	3,251
Dividends paid	3,388	3,420	3,369	3,311	1,982	1,562
Net cash from financing activities	(5,300)	(6,145)	(5,350)	(3,147)	1,098	(4,016)
Net change in cash	2,281	(70)	(909)	2,278	(333)	(365)

SIC 3841 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 3841 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
A cell reading “not reported” means the filings give no figure for that quarter alone.

Company	Cash ($M)	Revenue, quarter ($M)	Operating cash flow, quarter ($M)	Shares outstanding	Quarter
3M	4,835	6,584	486*	516.7M	Q3 FY26 10-QSep 30, 2026
Becton Dickinson	708	4,983	not reported	272.4M	Q3 FY26 10-QJun 30, 2026
Medtronic	1,691	9,756	1,793	1.3B	Q1 FY27 10-QJul 31, 2026
Edwards Lifesciences	2,907	1,741	652*	576.4M	Q2 FY26 10-QJun 30, 2026
Stryker	3,271	6,520	1,461*	380.7M	Q3 FY26 10-QSep 30, 2026
Boston Scientific	609	5,138	1,048*	1.4B	Q3 FY26 10-QSep 30, 2026
Resmed	1,011	1,415	422	140.7M	Q1 FY27 10-QSep 30, 2026
Dexcom	961	1,345	326*	373.0M	Q3 FY26 10-QSep 30, 2026
GE HealthCare Technologies	2,826	5,513	907*	452.1M	Q3 FY26 10-QSep 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.